Trials / Completed
CompletedNCT03109002
An Epidemiology Study of Treatment Resistant Depression in the United States (US)
Epidemiology of Treatment Resistant Depression in the US: Analysis of Health Services Databases
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200,000 (actual)
- Sponsor
- Janssen Research & Development, LLC · Industry
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe the epidemiology of Treatment Resistant Depression (TRD) in the US, including the population incidence of TRD, and TRD as a proportion of Pharmacologically Treated Depression (PTD), and stratify the estimates by sex and age group, with separate estimates for the Medicaid population, the Medicare population, and the privately insured population. Anonymized participants data will be used for the analysis.
Conditions
Timeline
- Start date
- 2017-01-15
- Primary completion
- 2017-05-18
- Completion
- 2017-05-18
- First posted
- 2017-04-11
- Last updated
- 2025-04-27
Source: ClinicalTrials.gov record NCT03109002. Inclusion in this directory is not an endorsement.